Privia Health Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRVA research report →
About the company
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person.
- CEO
- Parth Mehrotra
- IPO
- 2021
- Employees
- 1,140
- HQ
- Arlington, VA, US
Price Chart
- Market Cap
- $3.45B
- P/E
- 154.66
- P/S
- 1.53
- P/B
- 4.51
- EV/EBITDA
- 53.86
- Div Yield
- 0.00%
- Gross Margin
- 9.59%
- Op Margin
- 1.62%
- Net Margin
- 0.97%
- ROE
- 3.02%
- ROIC
- 2.70%
- Revenue
- $2.12B · 22.26%
- Net Income
- $22.92M · 59.33%
- EPS
- $0.19 · 58.33%
- Op Income
- $34.23M
- FCF YoY
- 55.57%
- 52W High
- $27.52
- 52W Low
- $18.77
- 50D MA
- $23.43
- 200D MA
- $23.40
- Beta
- 0.87
- Avg Volume
- 1.04M
Get TickerSpark's AI analysis on PRVA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Morris Matthew Shawn | other | 52,823 |
| Jul 1, 26 | Morris Matthew Shawn | other | 82,675 |
| Jul 1, 26 | Morris Matthew Shawn | other | 82,675 |
| Jun 30, 26 | Morris Matthew Shawn | other | 52,823 |
| Jul 1, 26 | Morris Matthew Shawn | sell | 45,634 |
| Jul 1, 26 | Morris Matthew Shawn | sell | 37,041 |
| Jun 30, 26 | Morris Matthew Shawn | sell | 52,823 |
| Jun 26, 26 | Morris Matthew Shawn | other | 88,110 |
| Jun 29, 26 | Morris Matthew Shawn | other | 63,212 |
| Jun 26, 26 | Morris Matthew Shawn | other | 88,110 |
Our PRVA coverage
Recent articles, reports, and earnings notes.
No research on PRVA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PRVA report →Similar companies
Peers in the same neighborhood.